Current:Home > NewsUS wholesale inflation accelerated in November in sign that some price pressures remain elevated -ProfitPioneers Hub
US wholesale inflation accelerated in November in sign that some price pressures remain elevated
View
Date:2025-04-16 17:39:44
WASHINGTON (AP) — Wholesale costs in the United States picked up sharply last month, signaling that price pressures are still evident in the economy even though inflation has tumbled from the peak levels it hit more than two years ago.
The Labor Department reported Thursday that its producer price index — which tracks inflation before it reaches consumers — rose 0.4% last month from October, up from 0.3% the month before. Measured from 12 months earlier, wholesale prices climbed 3% in November, the sharpest year-over-year rise since February 2023.
Excluding volatile food and energy prices, so-called core producer prices rose 0.2% from October and 3.4% from November 2023.
Higher food prices pushed up the November wholesale inflation reading, which came in hotter than economists had expected. Surging prices of fruits, vegetables and eggs drove wholesale food costs up 3.1% from October. They had been unchanged the month before.
The wholesale price report comes a day after the government reported that consumer prices rose 2.7% in Novemberfrom a year earlier, up from an annual gain of 2.6% in October. The increase, fueled by pricier used cars, hotel rooms and groceries, showed that elevated inflation has yet to be fully tamed.
Inflation in consumer prices has plummeted from a four-decade high 9.1% in June 2022. Yet despite having reached relatively low levels, it has so far remained persistently above the Fed’s 2% target.
Despite the modest upticks in inflation last month, the Federal Reserve is poised to cut its benchmark interest rate next week for a third consecutive time. In 2022 and 2023, the Fed raised its key short-term rate 11 times — to a two-decade high — in a drive to reverse an inflationary surge that followed the economy’s unexpectedly strong recovery from the COVID-19 recession. The steady cooling of inflation led the central bank, starting in the fall, to begin reversing that move.
In September, the Fed slashed its benchmark rate, which affects many consumer and business loans, by a sizable half-point. It followed that move with a quarter-point rate cut in November. Those cuts lowered the central bank’s key rate to 4.6%, down from a four-decade high of 5.3%.
The producer price index released Thursday can offer an early look at where consumer inflation might be headed. Economists also watch it because some of its components, notably healthcare and financial services, flow into the Fed’s preferred inflation gauge — the personal consumption expenditures, or PCE, index.
Despite the overall uptick in producer prices, Paul Ashworth of Capital Economics noted in a commentary that the components that feed into the PCE index were “universally weak” in November and make it even more likely that the Fed will cut its benchmark rate next week.
President-elect Donald Trump’s forthcoming agenda has raised concerns about the future path of inflation and whether the Fed will continue to cut rates. Though Trump has vowed to force prices down, in part by encouraging oil and gas drilling, some of his other campaign vows — to impose massive taxes on imports, for example, and to deport millions of immigrants working illegally in the United States — are widely seen as inflationary.
Still, Wall Street traders foresee a 98% likelihood of a third Fed rate cut next week, according to the CME FedWatch tool.
Disclaimer: The copyright of this article belongs to the original author. Reposting this article is solely for the purpose of information dissemination and does not constitute any investment advice. If there is any infringement, please contact us immediately. We will make corrections or deletions as necessary. Thank you.
veryGood! (21)
Related
- What to watch: O Jolie night
- Real Housewives of Beverly Hills Alum Lisa Rinna Shares $3 Picks To Refresh Your Beauty Routine
- Dunkin' faces $5M lawsuit: Customers say extra charge for non-dairy milk is discrimination
- Ex-US Open champ Scott Simpson details why he's anti-LIV, how Greg Norman became 'a jerk'
- How effective is the Hyundai, Kia anti-theft software? New study offers insights.
- Whether You're Rooting for the Chiefs or the 49ers, These Red Lipsticks Are Kiss-Proof
- 'Argylle' review: A great spy comedy premise is buried by secret-agent chaos
- Live, Laugh, Lululemon: Win Over Your Valentine's Heart With These Wishlist-Worthy Gifts
- Newly elected West Virginia lawmaker arrested and accused of making terroristic threats
- Predictions for MLB's top remaining 2024 free agents: Who will sign Cy Young winner?
Ranking
- Federal appeals court upholds $14.25 million fine against Exxon for pollution in Texas
- Why that rain scene in 'Killers of the Flower Moon' is so 'beautiful' to Martin Scorsese
- Tennessee attorney general sues NCAA over ‘NIL-recruiting ban’ as UT fights back
- Tennessee's fight with NCAA illustrates chaos in college athletics. Everyone is to blame
- Illinois governor calls for resignation of sheriff whose deputy fatally shot Black woman in her home
- What's next for Greg Olsen with Tom Brady in line to take No. 1 spot on FOX?
- California man who blamed twin brother for cold case rapes of girl and jogger is sentenced to 140 years in prison
- Below Deck's Ben Willoughby Reveals the Real Reason for Camille Lamb Breakup
Recommendation
Sarah J. Maas books explained: How to read 'ACOTAR,' 'Throne of Glass' in order.
Alexandra Park Shares Her Thoughts on Ozempic as a Type 1 Diabetic
Islamic Resistance in Iraq group is to blame for Jordan drone strike that killed 3 troops, US says
Could Aldi be opening near Las Vegas? Proposal shows plans for Nevada's first location.
Video shows dog chewing cellphone battery pack, igniting fire in Oklahoma home
Judge rejects school system’s request to toss out long-running sex-assault lawsuit
Cole Sprouse admits he doesn't remember a lot from filming 'Suite Life of Zack & Cody'
Biogen plans to shut down its controversial Alzheimer’s drug Aduhelm